Time Variations in the Risk of Myocardial Infarction Among Elderly Users of COX-2 Inhibitors

CMAJ - Canada
doi 10.1503/cmaj.051679
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Joule Inc.

Related search

Aspirin and Angiotensin-Converting Enzyme Inhibitors Among Elderly Survivors of Hospitalization for an Acute Myocardial Infarction

Archives of Internal Medicine
2001English

COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors

Gut
Gastroenterology
2000English

ST Elevation Myocardial Infarction in the Elderly

Journal of Geriatric Cardiology
GerontologyGeriatricsCardiovascular MedicineCardiology
2012English

LINC00528 Regulates Myocardial Infarction by Targeting the miR-143-3p/COX-2 Axis

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

Reduction in Cancer Risk by Selective and Nonselective Cyclooxygenase-2 (COX-2) Inhibitors

Journal of Experimental Pharmacology
Molecular MedicinePharmacology
2012English

Assessment of MI Myocardial Infarction Risk Factors Among Post-Mi

International Journal of Trend in Scientific Research and Development
2018English

The Risk of Acute Myocardial Infarction

Epidemiology
Epidemiology
2004English

Risk of Acute Myocardial Infarction Among New Users of Allopurinol According to Serum Urate Level: A Nested Case-Control Study

Journal of Clinical Medicine
2019English

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy